NCT02975752View on ClinicalTrials.gov

EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

November 30, 2016

Conditions
Lung Adenocarcinoma Metastatic
Interventions
GENETIC

LC-RT-PCR and NGS

highly sensitive PCR vs. multiplex targeted-resequencing

All Listed Sponsors
lead

University Hospital, Essen

OTHER

NCT02975752 - EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA | Biotech Hunter | Biotech Hunter